Skip to main content
SpringerLink
Log in

Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

A Correction to this article was published on 05 July 2019

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Change history

  • 05 July 2019

    The given names and family names of all authors were transposed in the original publication. The correct names are as shown above.

References

  1. Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377:1513–1524

    Article  CAS  Google Scholar 

  2. Gibson CM, Mehran R, Bode C et al (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 375:2423–2434

    Article  CAS  Google Scholar 

  3. Dewilde WJ, Oirbans T, Verheugt FW et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107–1115

    Article  CAS  Google Scholar 

  4. Lopes RD, Heizer G, Aronson R et al (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 380:1509–1524

    Article  CAS  Google Scholar 

  5. Cavallari I, Patti G (2018) Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol 121:718–724

    Article  Google Scholar 

  6. Lou B, Liang X, Wu Y et al (2018) Meta-analysis comparing dual versus single antiplatelet therapy in combination with antithrombotic therapy in patients with atrial fibrillation who underwent percutaneous coronary intervention with stent implantation. Am J Cardiol 122:604–611

    Article  Google Scholar 

  7. Golwala HB, Cannon CP, Steg PG et al (2018) Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials. Eur Heart J 39:1726–1735

    Article  CAS  Google Scholar 

  8. Duerschmied D, Brachmann J, Darius H et al (2018) Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Clin Res Cardiol 107:533–538

    Article  CAS  Google Scholar 

  9. Lee SY, Hong MK, Shin DH et al (2017) Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Clin Res Cardiol 106:165–173

    Article  CAS  Google Scholar 

  10. Vranckx P, Valgimigli M, Juni P et al (2018) Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 392:940–949

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria

    Bernhard Wernly & Michael Lichtenauer

  2. Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden

    David Erlinge

  3. Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany

    Christian Jung

Authors
  1. Bernhard Wernly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Lichtenauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Erlinge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christian Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Jung.

Additional information

The original version of this article was revised: The given names and family names of all authors were transposed in the original publication. The correct names are as shown above.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wernly, B., Lichtenauer, M., Erlinge, D. et al. Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?. Clin Res Cardiol 109, 128–130 (2020). https://doi.org/10.1007/s00392-019-01496-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-019-01496-w

Search

Navigation